Overview
Location
United States, Arizona, Oro Valley
Employees
11-50
Total raised
$4M
Founded date
2010
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 1, 2020 | BioDirection Closes $18M Series C Financing | BioDirection, Inc. d/b/a NanoDiagnostics, Inc., a Boston, MA-based medical device company, closed an $18m Series C financing. The round was led by the Alternative Investment division of Shepherd Kaplan Krochuk, LLC (SKK), a diversified Weal... |
| Jul 1, 2020 | BioDirection Closes $18 Million Series C Financing Led by Shepherd Kaplan Krochuk | BioDirection, Inc. d/b/a NanoDiagnostics, Inc. (NanoDxTM), a privately held medical device company developing cutting-edge and rapid point-of-care in-vitro diagnostic products for the objective detection, diagnosis and management of Traumat... |
| Sep 8, 2017 | FDA slaps SyncThink with warning letter over concussion detection claims | In response to the FDA’s demand that SyncThink stop misbranding its Eye-Sync device, the company said in an email that it had removed the claims from its website. “We have removed all of the references that the FDA have identified in their ... |
| Feb 4, 2016 | BioDirection Receives $4M | BOSTON, MA, BioDirection today announced that it has closed over $4 million in a Series B Convertible Preferred Stock financing. >> Click here for more funding data on BioDirection >> To export BioDirection funding data to P... |
| Feb 4, 2016 | BioDirection Closes over $4M in Series B Funding | BioDirection, Inc., a Boston, MA-based medical device company developing novel and rapid point-of-care products for the objective management of concussion and other traumatic brain injury (TBI), closed over $4m in a Series B Convertible Pre... |
| Feb 3, 2016 | BioDirection closes $4M Series B for concussion management product | Using just one drop of whole blood, the TBit technology can deliver results for detecting concussion and other TBI in 90 seconds, which reduces the need for CT scans and can allow for earlier treatment when necessary. Participants in the fi... |
| Jan 5, 2015 | Handheld device could detect concussion with a single drop of blood | Promoted This Patient Experience Checklist Is Your Key To Success in 2021 As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| Apr 10, 2013 | Hand-held concussion-screening device picks up $2.2 million; could launch this year | The technology was developed by Dr. Charles Lieber at Harvard University and licensed from Nanosys Inc., a company that designs and builds advanced materials. According to its website, BioDirection expects to launch the product, called Tbit... |
| Hand-held concussion-screening device picks up $2.2 million; could launch this year | A portable, hand-held device that uses a drop of blood to screen athletes and military personnel for concussions could soon be on the market if all goes well for an Arizona medical device startup. That company is BioDirection Inc. and it’s ... |
Show more
Reviews 0
FAQ about BioDirection Inc.
When was BioDirection Inc. founded?
BioDirection Inc. was founded in 2010.
How much funding has BioDirection Inc. raised?
BioDirection Inc. has raised $4M in total across 1 funding round.
What has the press written about BioDirection Inc.?
Parsers VC has collected 13 articles mentioning BioDirection Inc., among them “BioDirection Closes $18M Series C Financing” (Jul 1, 2020) and “BioDirection Closes $18 Million Series C Financing Led by Shepherd Kaplan Krochuk” (Jul 1, 2020).
Is BioDirection Inc. still active?
Yes, BioDirection Inc. is active; its latest activity on Parsers VC dates from Jul 2, 2020.